Purpurin as a specific inhibitor of spermidine-induced autoactivation of the protease plasma hyaluronan-binding protein.

Plasma hyaluronan-binding protein (PHBP), a serine protease that can activate coagulation factor VII and prourokinase, circulates as a single-chain form (pro-PHBP), and is autoproteolytically converted to an active two-chain form with the aid of an effector such as spermidine and heparin. In this study, we screened natural sources for inhibitors of spermidine-induced pro-PHBP autoactivation. As an active agent, we purified bikaverin from a culture of a fungus. Bikaverin inhibited spermidine-induced autoactivation with an IC(50) of 0.45 microM, while it also inhibited the active form of PHBP (IC(50)=0.8 microM). Additional screening of related compounds led to the identification of purpurin, a plant anthraquinone, as a specific inhibitor: IC(50)=6.6 microM for spermidine-induced autoactivation; no inhibition of heparin-induced autoactivation and active PHBP. Alizarin and emodin, which structurally differed from purpurin in the position or the number of the hydroxyl groups, were less active and nonspecific. Thus, the position and/or the number of the hydroxyl group affect both the potency and selectivity of the anthraquinone inhibitors.

[1]  M. Etscheid,et al.  Factor VII activating protease (FSAP): caught in the cross‐fire between polycations and polyanions , 2010, Journal of thrombosis and haemostasis : JTH.

[2]  K. Hasumi,et al.  Polyamine‐promoted autoactivation of plasma hyaluronan‐binding protein , 2010, Journal of thrombosis and haemostasis : JTH.

[3]  K. Preissner,et al.  Plasminogen Activator Inhibitor-1 Is an Inhibitor of Factor VII-activating Protease in Patients with Acute Respiratory Distress Syndrome* , 2007, Journal of Biological Chemistry.

[4]  K. Preissner,et al.  Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP). , 2005, The Biochemical journal.

[5]  K. Takahashi,et al.  Hepatic injury-specific conversion of mouse plasma hyaluronan binding protein to the active hetero-dimer form. , 2001, Biological & pharmaceutical bulletin.

[6]  A. Feussner,et al.  Quantitation of the factor VII- and single-chain plasminogen activator-activating protease in plasmas of healthy subjects , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[7]  K. Takahashi,et al.  Regulation mechanism of the serine protease activity of plasma hyaluronan binding protein. , 2001, Biological & pharmaceutical bulletin.

[8]  J. Römisch,et al.  The FVII Activating Protease Cleaves Single-Chain Plasminogen Activators , 2000, Pathophysiology of Haemostasis and Thrombosis.

[9]  J. Dodt,et al.  Activation of proPHBSP, the Zymogen of a Plasma Hyaluronan Binding Serine Protease, by an Intermolecular Autocatalytic Mechanism , 2000, Biological chemistry.

[10]  J. Römisch,et al.  A protease isolated from human plasma activating factor VII independent of tissue factor. , 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[11]  J. Dodt,et al.  Detection of a novel plasma serine protease during purification of vitamin K‐dependent coagulation factors , 1999, FEBS letters.

[12]  T. Tobe,et al.  Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. , 1996, Journal of biochemistry.